Evidence map›Paper›PMID 36291918›Full record

ReviewCancers2022

The Emerging Roles of Protein Interactions with O-GlcNAc Cycling Enzymes in Cancer.

Chia-Wei Hu, Jinshan Xie, Jiaoyang Jiang

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. O-GlcNAc informatics: advances and trends.Analytical and bioanalytical chemistry · 2025
    Review
  4. CanPharmaceuticals (Basel, Switzerland) · 2024
    Review
  5. Article
  6. Article
  7. Cells · 2023
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chia-Wei HuPharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA.
Jinshan XiePharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA.ORCID 0000-0003-4675-6965
Jiaoyang JiangPharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA.ORCID 0000-0001-8445-9924
University of Wisconsin–Madison · US

Funding

Chemical Probes to Characterize the Functional States of O-GlcNAc TransferaseR01GM121718 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Jiaoyang Jiang · 2017 to 2026
$3.3M
Structure, Function and Regulation of Human O-GlcNAcaseR01GM126300 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI JIANG, JIAOYANG · 2017 to 2020
$1.2M
NIGMS NIH HHS R01 GM121718NIGMS NIH HHS R01 GM126300NIH HHS R01 GM121718 and R01 GM126300
6 · The paper itself

Abstract

The dynamic O-GlcNAc modification of intracellular proteins is an important nutrient sensor for integrating metabolic signals into vast networks of highly coordinated cellular activities. Dysregulation of the sole enzymes responsible for O-GlcNAc cycling, O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), and the associated cellular O-GlcNAc profile is a common feature across nearly every cancer type. Many studies have investigated the effects of aberrant OGT/OGA expression on global O-GlcNAcylation activity in cancer cells. However, recent studies have begun to elucidate the roles of protein-protein interactions (PPIs), potentially through regions outside of the immediate catalytic site of OGT/OGA, that regulate greater protein networks to facilitate substrate-specific modification, protein translocalization, and the assembly of larger biomolecular complexes. Perturbation of OGT/OGA PPI networks makes profound changes in the cell and may directly contribute to cancer malignancies. Herein, we highlight recent studies on the structural features of OGT and OGA, as well as the emerging roles and molecular mechanisms of their aberrant PPIs in rewiring cancer networks. By integrating complementary approaches, the research in this area will aid in the identification of key protein contacts and functional modules derived from OGT/OGA that drive oncogenesis and will illuminate new directions for anti-cancer drug development.

Indexed as

cancerO-GlcNAcase (OGA)O-GlcNAc transferase (OGT)O-GlcNAcylationprotein–protein interaction (PPI)

Identifiers

PMID36291918
PMCPMC9600386
OpenAlexW4306938197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.